 | • レポートコード：QY2108PAL8831 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおける機能性消化不良治療薬の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、機能性消化不良治療薬の種類別市場規模（運動促進薬、胃抗分泌薬、その他）、用途別市場規模（病院、ドラッグストア）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界の機能性消化不良治療薬市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界における機能性消化不良治療薬の種類別市場規模（2016年-2027年）：運動促進薬、胃抗分泌薬、その他 ・世界における機能性消化不良治療薬の用途別市場規模（2016年-2027年）：病院、ドラッグストア ・機能性消化不良治療薬の中国市場分析 - 機能性消化不良治療薬の中国市場規模（2016年-2027年） - 中国における機能性消化不良治療薬の主要プレイヤー別市場シェア - 中国における機能性消化不良治療薬の種類別市場規模：運動促進薬、胃抗分泌薬、その他 - 中国における機能性消化不良治療薬の用途別市場規模：病院、ドラッグストア ・機能性消化不良治療薬の北米市場（2016年-2027年） ・機能性消化不良治療薬のヨーロッパ市場（2016年-2027年） ・機能性消化不良治療薬のアジア太平洋市場（2016年-2027年） ・機能性消化不良治療薬の中南米市場（2016年-2027年） ・機能性消化不良治療薬の中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Bayer、Sumitomo、Cadila Pharmaceuticals、Teva、Johnson & Johnson、Pfizer、Sanofi、AstraZeneca、Jiangsu Aosaikang Pharma、Eisai、Kyowa Kirin Pharmaceuticals、Hanmi Pharm ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Functional dyspepsia, also known as non-ulcer dyspepsia or indigestion, is a term used to describe a group of symptoms affecting the gastrointestinal tract, including stomach pain or discomfort, nausea, bloating and belching. The condition is diagnosed when no obvious cause can be found for the symptoms present, though a small percentage of cases are caused by infection with the germ Helicobacter pylori.
North America is the largest consumer of Functional Dyspepsia Drug in global market, with a consumption market share of 38.71% in 2019. Market is not concentrated.
Market Analysis and Insights: Global and China Functional Dyspepsia Drug Market
This report focuses on global and China Functional Dyspepsia Drug market.
In 2020, the global Functional Dyspepsia Drug market size was US$ 5783.5 million and it is expected to reach US$ 7020.9 million by the end of 2027, with a CAGR of 2.8% during 2021-2027. In China the Functional Dyspepsia Drug market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Functional Dyspepsia Drug Scope and Market Size
Functional Dyspepsia Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Functional Dyspepsia Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Functional Dyspepsia Drug market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Prokinetic Drugs
Gastric Antisecretory Drugs
Others
The classification of Functional Dyspepsia Drug includes Prokinetic Drugs, Gastric Antisecretory Drugs, etc. The proportion of Gastric Antisecretory Drugs in 2019 is about 47.86%.
Segment by Application
Hospitals
Drugstores
The application of Functional Dyspepsia Drug includes hospitals and drugstores. The proportion of hospitals in 2019 is about 63.85%.
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Bayer
Sumitomo
Cadila Pharmaceuticals
Teva
Johnson & Johnson
Pfizer
Sanofi
AstraZeneca
Jiangsu Aosaikang Pharma
Eisai
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
1 Study Coverage
1.1 Functional Dyspepsia Drug Product Introduction
1.2 Market by Type
1.2.1 Global Functional Dyspepsia Drug Market Size Growth Rate by Type
1.2.2 Prokinetic Drugs
1.2.3 Gastric Antisecretory Drugs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Functional Dyspepsia Drug Market Size Growth Rate by Application
1.3.2 Hospitals
1.3.3 Drugstores
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Functional Dyspepsia Drug Market Size, Estimates and Forecasts
2.1.1 Global Functional Dyspepsia Drug Revenue 2016-2027
2.1.2 Global Functional Dyspepsia Drug Sales 2016-2027
2.2 Global Functional Dyspepsia Drug, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Functional Dyspepsia Drug Historical Market Size by Region (2016-2021)
2.3.1 Global Functional Dyspepsia Drug Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Functional Dyspepsia Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Functional Dyspepsia Drug Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Functional Dyspepsia Drug Sales Forecast by Region (2022-2027)
2.4.2 Global Functional Dyspepsia Drug Revenue Forecast by Region (2022-2027)
3 Global Functional Dyspepsia Drug Competitor Landscape by Players
3.1 Global Top Functional Dyspepsia Drug Manufacturers by Sales
3.1.1 Global Functional Dyspepsia Drug Sales by Manufacturer (2016-2021)
3.1.2 Global Functional Dyspepsia Drug Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Functional Dyspepsia Drug Manufacturers by Revenue
3.2.1 Key Functional Dyspepsia Drug Manufacturers Covered: Ranking by Revenue
3.2.2 Global Functional Dyspepsia Drug Revenue by Manufacturers (2016-2021)
3.2.3 Global Functional Dyspepsia Drug Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Functional Dyspepsia Drug Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Functional Dyspepsia Drug Revenue in 2020
3.2.6 Global Functional Dyspepsia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Functional Dyspepsia Drug Price by Manufacturers
3.4 Global Functional Dyspepsia Drug Manufacturing Base Distribution, Product Types
3.4.1 Functional Dyspepsia Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Functional Dyspepsia Drug Product Type
3.4.3 Date of International Manufacturers Enter into Functional Dyspepsia Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Functional Dyspepsia Drug Market Size by Type (2016-2021)
4.1.1 Global Functional Dyspepsia Drug Sales by Type (2016-2021)
4.1.2 Global Functional Dyspepsia Drug Revenue by Type (2016-2021)
4.1.3 Functional Dyspepsia Drug Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Functional Dyspepsia Drug Market Size Forecast by Type (2022-2027)
4.2.1 Global Functional Dyspepsia Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Functional Dyspepsia Drug Revenue Forecast by Type (2022-2027)
4.2.3 Functional Dyspepsia Drug Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Functional Dyspepsia Drug Market Size by Application (2016-2021)
5.1.1 Global Functional Dyspepsia Drug Sales by Application (2016-2021)
5.1.2 Global Functional Dyspepsia Drug Revenue by Application (2016-2021)
5.1.3 Functional Dyspepsia Drug Price by Application (2016-2021)
5.2 Functional Dyspepsia Drug Market Size Forecast by Application (2022-2027)
5.2.1 Global Functional Dyspepsia Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Functional Dyspepsia Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Functional Dyspepsia Drug Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Functional Dyspepsia Drug Market Size YoY Growth 2016-2027
6.1.1 China Functional Dyspepsia Drug Sales YoY Growth 2016-2027
6.1.2 China Functional Dyspepsia Drug Revenue YoY Growth 2016-2027
6.1.3 China Functional Dyspepsia Drug Market Share in Global Market 2016-2027
6.2 China Functional Dyspepsia Drug Market Size by Players (International and Local Players)
6.2.1 China Top Functional Dyspepsia Drug Players by Sales (2016-2021)
6.2.2 China Top Functional Dyspepsia Drug Players by Revenue (2016-2021)
6.3 China Functional Dyspepsia Drug Historic Market Review by Type (2016-2021)
6.3.1 China Functional Dyspepsia Drug Sales Market Share by Type (2016-2021)
6.3.2 China Functional Dyspepsia Drug Revenue Market Share by Type (2016-2021)
6.3.3 China Functional Dyspepsia Drug Price by Type (2016-2021)
6.4 China Functional Dyspepsia Drug Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Functional Dyspepsia Drug Sales Forecast by Type (2022-2027)
6.4.2 China Functional Dyspepsia Drug Revenue Forecast by Type (2022-2027)
6.4.3 China Functional Dyspepsia Drug Price Forecast by Type (2022-2027)
6.5 China Functional Dyspepsia Drug Historic Market Review by Application (2016-2021)
6.5.1 China Functional Dyspepsia Drug Sales Market Share by Application (2016-2021)
6.5.2 China Functional Dyspepsia Drug Revenue Market Share by Application (2016-2021)
6.5.3 China Functional Dyspepsia Drug Price by Application (2016-2021)
6.6 China Functional Dyspepsia Drug Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Functional Dyspepsia Drug Sales Forecast by Application (2022-2027)
6.6.2 China Functional Dyspepsia Drug Revenue Forecast by Application (2022-2027)
6.6.3 China Functional Dyspepsia Drug Price Forecast by Application (2022-2027)
7 North America
7.1 North America Functional Dyspepsia Drug Market Size YoY Growth 2016-2027
7.2 North America Functional Dyspepsia Drug Market Facts & Figures by Country
7.2.1 North America Functional Dyspepsia Drug Sales by Country (2016-2021)
7.2.2 North America Functional Dyspepsia Drug Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Functional Dyspepsia Drug Market Size YoY Growth 2016-2027
8.2 Asia Pacific Functional Dyspepsia Drug Market Facts & Figures by Region
8.2.1 Asia Pacific Functional Dyspepsia Drug Sales by Region (2016-2021)
8.2.2 Asia Pacific Functional Dyspepsia Drug Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Functional Dyspepsia Drug Market Size YoY Growth 2016-2027
9.2 Europe Functional Dyspepsia Drug Market Facts & Figures by Country
9.2.1 Europe Functional Dyspepsia Drug Sales by Country (2016-2021)
9.2.2 Europe Functional Dyspepsia Drug Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Functional Dyspepsia Drug Market Size YoY Growth 2016-2027
10.2 Latin America Functional Dyspepsia Drug Market Facts & Figures by Country
10.2.1 Latin America Functional Dyspepsia Drug Sales by Country (2016-2021)
10.2.2 Latin America Functional Dyspepsia Drug Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Functional Dyspepsia Drug Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Functional Dyspepsia Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Functional Dyspepsia Drug Sales by Country (2016-2021)
11.2.2 Middle East and Africa Functional Dyspepsia Drug Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Bayer
12.1.1 Bayer Corporation Information
12.1.2 Bayer Description and Business Overview
12.1.3 Bayer Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bayer Functional Dyspepsia Drug Products Offered
12.1.5 Bayer Recent Development
12.2 Sumitomo
12.2.1 Sumitomo Corporation Information
12.2.2 Sumitomo Description and Business Overview
12.2.3 Sumitomo Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sumitomo Functional Dyspepsia Drug Products Offered
12.2.5 Sumitomo Recent Development
12.3 Cadila Pharmaceuticals
12.3.1 Cadila Pharmaceuticals Corporation Information
12.3.2 Cadila Pharmaceuticals Description and Business Overview
12.3.3 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Cadila Pharmaceuticals Functional Dyspepsia Drug Products Offered
12.3.5 Cadila Pharmaceuticals Recent Development
12.4 Teva
12.4.1 Teva Corporation Information
12.4.2 Teva Description and Business Overview
12.4.3 Teva Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Teva Functional Dyspepsia Drug Products Offered
12.4.5 Teva Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Corporation Information
12.5.2 Johnson & Johnson Description and Business Overview
12.5.3 Johnson & Johnson Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Johnson & Johnson Functional Dyspepsia Drug Products Offered
12.5.5 Johnson & Johnson Recent Development
12.6 Pfizer
12.6.1 Pfizer Corporation Information
12.6.2 Pfizer Description and Business Overview
12.6.3 Pfizer Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Pfizer Functional Dyspepsia Drug Products Offered
12.6.5 Pfizer Recent Development
12.7 Sanofi
12.7.1 Sanofi Corporation Information
12.7.2 Sanofi Description and Business Overview
12.7.3 Sanofi Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Sanofi Functional Dyspepsia Drug Products Offered
12.7.5 Sanofi Recent Development
12.8 AstraZeneca
12.8.1 AstraZeneca Corporation Information
12.8.2 AstraZeneca Description and Business Overview
12.8.3 AstraZeneca Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 AstraZeneca Functional Dyspepsia Drug Products Offered
12.8.5 AstraZeneca Recent Development
12.9 Jiangsu Aosaikang Pharma
12.9.1 Jiangsu Aosaikang Pharma Corporation Information
12.9.2 Jiangsu Aosaikang Pharma Description and Business Overview
12.9.3 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Products Offered
12.9.5 Jiangsu Aosaikang Pharma Recent Development
12.10 Eisai
12.10.1 Eisai Corporation Information
12.10.2 Eisai Description and Business Overview
12.10.3 Eisai Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Eisai Functional Dyspepsia Drug Products Offered
12.10.5 Eisai Recent Development
12.11 Bayer
12.11.1 Bayer Corporation Information
12.11.2 Bayer Description and Business Overview
12.11.3 Bayer Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Bayer Functional Dyspepsia Drug Products Offered
12.11.5 Bayer Recent Development
12.12 Hanmi Pharm
12.12.1 Hanmi Pharm Corporation Information
12.12.2 Hanmi Pharm Description and Business Overview
12.12.3 Hanmi Pharm Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Hanmi Pharm Products Offered
12.12.5 Hanmi Pharm Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Functional Dyspepsia Drug Industry Trends
13.2 Functional Dyspepsia Drug Market Drivers
13.3 Functional Dyspepsia Drug Market Challenges
13.4 Functional Dyspepsia Drug Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Functional Dyspepsia Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Functional Dyspepsia Drug Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Prokinetic Drugs
Table 3. Major Manufacturers of Gastric Antisecretory Drugs
Table 4. Major Manufacturers of Others
Table 5. Global Functional Dyspepsia Drug Market Size Growth Rate by Application (2021-2027) & (M Units)
Table 6. Global Functional Dyspepsia Drug Market Size by Region (M Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Functional Dyspepsia Drug Sales by Regions (2016-2021) & (M Units)
Table 8. Global Functional Dyspepsia Drug Sales Market Share by Regions (2016-2021)
Table 9. Global Functional Dyspepsia Drug Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Functional Dyspepsia Drug Sales Forecast by Region (2022-2027) & (M Units)
Table 11. Global Functional Dyspepsia Drug Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Functional Dyspepsia Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Functional Dyspepsia Drug Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Functional Dyspepsia Drug Sales by Manufacturers (2016-2021) (M Units)
Table 15. Global Functional Dyspepsia Drug Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Functional Dyspepsia Drug Manufacturers by Revenue (US$ Million) in 2020
Table 17. Functional Dyspepsia Drug Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Functional Dyspepsia Drug Revenue Share by Manufacturers (2016-2021)
Table 19. Global Functional Dyspepsia Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Functional Dyspepsia Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Functional Dyspepsia Drug as of 2020)
Table 21. Key Manufacturers Functional Dyspepsia Drug Price (2016-2021) (US$/Unit)
Table 22. Functional Dyspepsia Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Functional Dyspepsia Drug Product Type
Table 24. Date of International Manufacturers Enter into Functional Dyspepsia Drug Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Functional Dyspepsia Drug Sales by Type (2016-2021) (M Units)
Table 27. Global Functional Dyspepsia Drug Sales Share by Type (2016-2021)
Table 28. Global Functional Dyspepsia Drug Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Functional Dyspepsia Drug Revenue Share by Type (2016-2021)
Table 30. Functional Dyspepsia Drug Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 31. Global Functional Dyspepsia Drug Sales Forecast by Type (2022-2027) & (M Units)
Table 32. Global Functional Dyspepsia Drug Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Functional Dyspepsia Drug Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Functional Dyspepsia Drug Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Functional Dyspepsia Drug Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 36. Global Functional Dyspepsia Drug Sales by Application (2016-2021) (M Units)
Table 37. Global Functional Dyspepsia Drug Sales Share by Application (2016-2021)
Table 38. Global Functional Dyspepsia Drug Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Functional Dyspepsia Drug Revenue Share by Application (2016-2021)
Table 40. Functional Dyspepsia Drug Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 41. Global Functional Dyspepsia Drug Sales Forecast by Application (2022-2027) & (M Units)
Table 42. Global Functional Dyspepsia Drug Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Functional Dyspepsia Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Functional Dyspepsia Drug Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Functional Dyspepsia Drug Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 46. China Functional Dyspepsia Drug Sales (M Units) of Key Companies (2016-2021)
Table 47. China Functional Dyspepsia Drug Sales Share by Company (2016-2021)
Table 48. China Functional Dyspepsia Drug Revenue (US$ Million) by Company (2016-2021)
Table 49. China Functional Dyspepsia Drug Revenue Share by Company (2016-2021)
Table 50. China Functional Dyspepsia Drug Sales (M Units) by Type (2016-2021)
Table 51. China Functional Dyspepsia Drug Sales Share by Type (2016-2021)
Table 52. China Functional Dyspepsia Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China Functional Dyspepsia Drug Price (US$/Unit) by Type (2016-2021)
Table 54. China Functional Dyspepsia Drug Sales (M Units) by Type (2022-2027)
Table 55. China Functional Dyspepsia Drug Sales Share by Type (2022-2027)
Table 56. China Functional Dyspepsia Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China Functional Dyspepsia Drug Revenue Share by Type (2022-2027)
Table 58. China Functional Dyspepsia Drug Price (US$/Unit) by Type (2022-2027)
Table 59. China Functional Dyspepsia Drug Sales (M Units) by Application (2016-2021)
Table 60. China Functional Dyspepsia Drug Sales Share by Application (2016-2021)
Table 61. China Functional Dyspepsia Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China Functional Dyspepsia Drug Price (US$/Unit) by Application (2016-2021)
Table 63. China Functional Dyspepsia Drug Sales (M Units) by Application (2022-2027)
Table 64. China Functional Dyspepsia Drug Sales Share by Application (2022-2027)
Table 65. China Functional Dyspepsia Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China Functional Dyspepsia Drug Revenue Share by Application (2022-2027)
Table 67. China Functional Dyspepsia Drug Price (US$/Unit) by Application (2022-2027)
Table 68. North America Functional Dyspepsia Drug Sales by Country (2016-2021) & (M Units)
Table 69. North America Functional Dyspepsia Drug Sales Market Share by Country (2016-2021)
Table 70. North America Functional Dyspepsia Drug Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Functional Dyspepsia Drug Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Functional Dyspepsia Drug Sales by Region (2016-2021) & (M Units)
Table 73. Asia Pacific Functional Dyspepsia Drug Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Functional Dyspepsia Drug Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Functional Dyspepsia Drug Revenue Market Share by Region (2016-2021)
Table 76. Europe Functional Dyspepsia Drug Sales by Country (2016-2021) & (M Units)
Table 77. Europe Functional Dyspepsia Drug Sales Market Share by Country (2016-2021)
Table 78. Europe Functional Dyspepsia Drug Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Functional Dyspepsia Drug Revenue Market Share by Country (2016-2021)
Table 80. Latin America Functional Dyspepsia Drug Sales by Country (2016-2021) & (M Units)
Table 81. Latin America Functional Dyspepsia Drug Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Functional Dyspepsia Drug Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Functional Dyspepsia Drug Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Functional Dyspepsia Drug Sales by Country (2016-2021) & (M Units)
Table 85. Middle East and Africa Functional Dyspepsia Drug Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Functional Dyspepsia Drug Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Functional Dyspepsia Drug Revenue Market Share by Country (2016-2021)
Table 88. Bayer Corporation Information
Table 89. Bayer Description and Business Overview
Table 90. Bayer Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Bayer Functional Dyspepsia Drug Product
Table 92. Bayer Recent Development
Table 93. Sumitomo Corporation Information
Table 94. Sumitomo Description and Business Overview
Table 95. Sumitomo Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Sumitomo Product
Table 97. Sumitomo Recent Development
Table 98. Cadila Pharmaceuticals Corporation Information
Table 99. Cadila Pharmaceuticals Description and Business Overview
Table 100. Cadila Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Cadila Pharmaceuticals Product
Table 102. Cadila Pharmaceuticals Recent Development
Table 103. Teva Corporation Information
Table 104. Teva Description and Business Overview
Table 105. Teva Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Teva Product
Table 107. Teva Recent Development
Table 108. Johnson & Johnson Corporation Information
Table 109. Johnson & Johnson Description and Business Overview
Table 110. Johnson & Johnson Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Johnson & Johnson Product
Table 112. Johnson & Johnson Recent Development
Table 113. Pfizer Corporation Information
Table 114. Pfizer Description and Business Overview
Table 115. Pfizer Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Pfizer Product
Table 117. Pfizer Recent Development
Table 118. Sanofi Corporation Information
Table 119. Sanofi Description and Business Overview
Table 120. Sanofi Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Sanofi Product
Table 122. Sanofi Recent Development
Table 123. AstraZeneca Corporation Information
Table 124. AstraZeneca Description and Business Overview
Table 125. AstraZeneca Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. AstraZeneca Product
Table 127. AstraZeneca Recent Development
Table 128. Jiangsu Aosaikang Pharma Corporation Information
Table 129. Jiangsu Aosaikang Pharma Description and Business Overview
Table 130. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Jiangsu Aosaikang Pharma Product
Table 132. Jiangsu Aosaikang Pharma Recent Development
Table 133. Eisai Corporation Information
Table 134. Eisai Description and Business Overview
Table 135. Eisai Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. Eisai Product
Table 137. Eisai Recent Development
Table 138. Kyowa Kirin Pharmaceuticals Corporation Information
Table 139. Kyowa Kirin Pharmaceuticals Description and Business Overview
Table 140. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 141. Kyowa Kirin Pharmaceuticals Product
Table 142. Kyowa Kirin Pharmaceuticals Recent Development
Table 143. Hanmi Pharm Corporation Information
Table 144. Hanmi Pharm Description and Business Overview
Table 145. Hanmi Pharm Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 146. Hanmi Pharm Product
Table 147. Hanmi Pharm Recent Development
Table 148. Functional Dyspepsia Drug Market Trends
Table 149. Functional Dyspepsia Drug Market Drivers
Table 150. Functional Dyspepsia Drug Market Challenges
Table 151. Functional Dyspepsia Drug Market Restraints
Table 152. Functional Dyspepsia Drug Customers List
Table 153. Functional Dyspepsia Drug Distributors List
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Functional Dyspepsia Drug Product Picture
Figure 2. Global Functional Dyspepsia Drug Sales Market Share by Type in 2020 & 2027
Figure 3. Prokinetic Drugs Product Picture
Figure 4. Gastric Antisecretory Drugs Product Picture
Figure 5. Others Product Picture
Figure 6. Global Functional Dyspepsia Drug Sales Market Share by Application in 2020 & 2027
Figure 7. Hospitals
Figure 8. Drugstores
Figure 9. Functional Dyspepsia Drug Report Years Considered
Figure 10. Global Functional Dyspepsia Drug Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Functional Dyspepsia Drug Market Size 2016-2027 (US$ Million)
Figure 12. Global Functional Dyspepsia Drug Sales 2016-2027 (M Units)
Figure 13. Global Functional Dyspepsia Drug Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Functional Dyspepsia Drug Sales Market Share by Region (2016-2021)
Figure 15. Global Functional Dyspepsia Drug Sales Market Share by Region in 2020
Figure 16. Global Functional Dyspepsia Drug Revenue Market Share by Region (2016-2021)
Figure 17. Global Functional Dyspepsia Drug Revenue Market Share by Region in 2020
Figure 18. Global Functional Dyspepsia Drug Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Functional Dyspepsia Drug Revenue in 2020
Figure 20. Functional Dyspepsia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Functional Dyspepsia Drug Sales Market Share by Type (2016-2021)
Figure 22. Global Functional Dyspepsia Drug Sales Market Share by Type in 2020
Figure 23. Global Functional Dyspepsia Drug Revenue Market Share by Type (2016-2021)
Figure 24. Global Functional Dyspepsia Drug Revenue Market Share by Type in 2020
Figure 25. Global Functional Dyspepsia Drug Sales Market Share by Application (2016-2021)
Figure 26. Global Functional Dyspepsia Drug Sales Market Share by Application in 2020
Figure 27. Global Functional Dyspepsia Drug Revenue Market Share by Application (2016-2021)
Figure 28. Global Functional Dyspepsia Drug Revenue Market Share by Application in 2020
Figure 29. China Functional Dyspepsia Drug Sales Growth Rate 2016-2027 (M Units)
Figure 30. China Functional Dyspepsia Drug Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. China Functional Dyspepsia Drug Market Share in Global Market 2016-2027
Figure 32. China 5 and 10 Largest Functional Dyspepsia Drug Players Market Share by Revenue in Functional Dyspepsia Drug in 2020
Figure 33. China Functional Dyspepsia Drug Revenue Share by Type (2016-2021)
Figure 34. China Functional Dyspepsia Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 35. China Functional Dyspepsia Drug Revenue Share by Application (2016-2021)
Figure 36. China Functional Dyspepsia Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Functional Dyspepsia Drug Sales Growth Rate 2016-2021 (M Units)
Figure 38. North America Functional Dyspepsia Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Functional Dyspepsia Drug Sales Market Share by Country in 2020
Figure 40. North America Functional Dyspepsia Drug Revenue Market Share by Country in 2020
Figure 41. U.S. Functional Dyspepsia Drug Sales Growth Rate (2016-2021) (M Units)
Figure 42. U.S. Functional Dyspepsia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Functional Dyspepsia Drug Sales Growth Rate (2016-2021) (M Units)
Figure 44. Canada Functional Dyspepsia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Functional Dyspepsia Drug Sales Growth Rate 2016-2021 (M Units)
Figure 46. Europe Functional Dyspepsia Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Functional Dyspepsia Drug Sales Market Share by Country in 2020
Figure 48. Europe Functional Dyspepsia Drug Revenue Market Share by Country in 2020
Figure 49. Germany Functional Dyspepsia Drug Sales Growth Rate (2016-2021) (M Units)
Figure 50. Germany Functional Dyspepsia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Functional Dyspepsia Drug Sales Growth Rate (2016-2021) (M Units)
Figure 52. France Functional Dyspepsia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Functional Dyspepsia Drug Sales Growth Rate (2016-2021) (M Units)
Figure 54. U.K. Functional Dyspepsia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Functional Dyspepsia Drug Sales Growth Rate (2016-2021) (M Units)
Figure 56. Italy Functional Dyspepsia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Functional Dyspepsia Drug Sales Growth Rate (2016-2021) (M Units)
Figure 58. Russia Functional Dyspepsia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Functional Dyspepsia Drug Sales Growth Rate 2016-2021 (M Units)
Figure 60. Asia Pacific Functional Dyspepsia Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Functional Dyspepsia Drug Sales Market Share by Region in 2020
Figure 62. Asia Pacific Functional Dyspepsia Drug Revenue Market Share by Region in 2020
Figure 63. China Functional Dyspepsia Drug Sales Growth Rate (2016-2021) (M Units)
Figure 64. China Functional Dyspepsia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Functional Dyspepsia Drug Sales Growth Rate (2016-2021) (M Units)
Figure 66. Japan Functional Dyspepsia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Functional Dyspepsia Drug Sales Growth Rate (2016-2021) (M Units)
Figure 68. South Korea Functional Dyspepsia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Functional Dyspepsia Drug Sales Growth Rate (2016-2021) (M Units)
Figure 70. India Functional Dyspepsia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Functional Dyspepsia Drug Sales Growth Rate (2016-2021) (M Units)
Figure 72. Australia Functional Dyspepsia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Taiwan Functional Dyspepsia Drug Sales Growth Rate (2016-2021) (M Units)
Figure 74. Taiwan Functional Dyspepsia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Functional Dyspepsia Drug Sales Growth Rate (2016-2021) (M Units)
Figure 76. Indonesia Functional Dyspepsia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Functional Dyspepsia Drug Sales Growth Rate (2016-2021) (M Units)
Figure 78. Thailand Functional Dyspepsia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Functional Dyspepsia Drug Sales Growth Rate (2016-2021) (M Units)
Figure 80. Malaysia Functional Dyspepsia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Philippines Functional Dyspepsia Drug Sales Growth Rate (2016-2021) (M Units)
Figure 82. Philippines Functional Dyspepsia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Vietnam Functional Dyspepsia Drug Sales Growth Rate (2016-2021) (M Units)
Figure 84. Vietnam Functional Dyspepsia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Latin America Functional Dyspepsia Drug Sales Growth Rate 2016-2021 (M Units)
Figure 86. Latin America Functional Dyspepsia Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 87. Latin America Functional Dyspepsia Drug Sales Market Share by Country in 2020
Figure 88. Latin America Functional Dyspepsia Drug Revenue Market Share by Country in 2020
Figure 89. Mexico Functional Dyspepsia Drug Sales Growth Rate (2016-2021) (M Units)
Figure 90. Mexico Functional Dyspepsia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Brazil Functional Dyspepsia Drug Sales Growth Rate (2016-2021) (M Units)
Figure 92. Brazil Functional Dyspepsia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Argentina Functional Dyspepsia Drug Sales Growth Rate (2016-2021) (M Units)
Figure 94. Argentina Functional Dyspepsia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Middle East and Africa Functional Dyspepsia Drug Sales Growth Rate 2016-2021 (M Units)
Figure 96. Middle East and Africa Functional Dyspepsia Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 97. Middle East and Africa Functional Dyspepsia Drug Sales Market Share by Country in 2020
Figure 98. Middle East and Africa Functional Dyspepsia Drug Revenue Market Share by Country in 2020
Figure 99. Turkey Functional Dyspepsia Drug Sales Growth Rate (2016-2021) (M Units)
Figure 100. Turkey Functional Dyspepsia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Saudi Arabia Functional Dyspepsia Drug Sales Growth Rate (2016-2021) (M Units)
Figure 102. Saudi Arabia Functional Dyspepsia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. UAE Functional Dyspepsia Drug Sales Growth Rate (2016-2021) (M Units)
Figure 104. UAE Functional Dyspepsia Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. Functional Dyspepsia Drug Value Chain
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Bottom-up and Top-down Approaches for This Report
Figure 109. Data Triangulation
Figure 110. Key Executives Interviewed
非機能性チューインガムの世界及び中国市場 Chewing gum is a kind of candy for chewing rather than swallowing. Traditionally, it is made from sugar gum. The statistic scope in this report excludes buddle gum. Global Non-Functional Chewing Gum key players include Mars, Mondelez, Lotte, Perfetti Van Melle, Orion, etc. Global top 5 manufacturers…- ヒドロキシ機能性樹脂の世界及び中国市場 Hydroxy functional resins refer to resins with hydroxy group connected on the molecular chain. After reaction with crosslinking agents like Melamine, the hydroxy functional resins possess good performance of chemical resistance and physical properties, making it advantageous to be used as coating in…
- 機能性キノコの世界及び中国市場 Functional mushroom specifically refers to varieties that have a health benefit beyond providing nutrition. Common advantages cited by proponents of the functional mushroom trend include anti-inflammatory properties – helpful for people with a variety of medical conditions that include inflammation …
- 機能性グミの世界及び中国市場 Functional gummies, also called Nutraceutical Gummies, are one of the fastest growing nutraceutical segments across Europe, North America and Asia. It usually contains various vitamin, DHA, Omega-3, Probiotics, minerals and other functionalities actives. Functional gummies are mainly classified into…
- 機能安全R&Dの世界市場 2020年 Market Overview The Functional Safety R&D market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…